ASPIRE BIOPHARMA HOLDINGS, INC. Current Assets
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) had Current Assets of $13.47 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $13.47M.
- 2026-03-31: Assets, Current $7.12M.
- 2025-12-31: Assets, Current $1.31M.
- 2025-09-30: Assets, Current $2.40M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $13.47M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $7.12M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.31M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $2.40M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $989.42K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.97M 10-Q/A · filed 2025-08-13 | |
| 2024-12-31 | $147.99K S-1/A · filed 2026-04-10 | $45.84K 10-K · filed 2025-04-07 |
| 2024-09-30 | $61.81K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $342.97K 10-Q · filed 2024-08-16 | |
| 2024-03-31 | $65.58K 10-Q · filed 2024-06-05 | |
| 2023-12-31 | $81.22K 10-K · filed 2025-04-07 | |
| 2023-09-30 | $253.36K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $546.14K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $906.46K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.10M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $1.15M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.21M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.26M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $293.22K 10-K · filed 2023-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |